<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35586752</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2590-1613</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>European journal of obstetrics &amp; gynecology and reproductive biology: X</Title>
          <ISOAbbreviation>Eur J Obstet Gynecol Reprod Biol X</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of NF1 and RASA1 gene expression in endometriosis.</ArticleTitle>
        <Pagination>
          <StartPage>100152</StartPage>
          <MedlinePgn>100152</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">100152</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eurox.2022.100152</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Endometrios affecting 6-10% of women of reproductive ages around the globe. Important pathways, including the MAPK and PI3K / Akt pathways, have been identified in the disease. The NF1 and RASA1 genes inactivate Ras by their own GTPase activity and controlled the high activity of these pathways.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">In this study, we measured NF1 and RASA1 gene expression in the endometrial tissues of patients (eutopic and ectopic tissues) compared to the control samples.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">In our study, tissue samples were collected from 15 patients with endometriosis and 15 healthy women. We used quantitative polymerase chain reaction (qRT-PCR) to measure the NF1 and RASA1 gene expression levels in these samples.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We observed a significant decrease in the expression level of the NF1 gene in both eutopic and ectopic samples of endometriosis patients compared to control samples, while the expression of the RASA1 gene was significantly reduced only in ectopic tissues.</AbstractText>
          <CopyrightInformation>© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yarahmadi</LastName>
            <ForeName>Ghafour</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dehghanian</LastName>
            <ForeName>Mehran</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sandoghsaz</LastName>
            <ForeName>Reyhaneh Sadat</ForeName>
            <Initials>RS</Initials>
            <AffiliationInfo>
              <Affiliation>Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Savaee</LastName>
            <ForeName>Mohamadreza</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shamsi</LastName>
            <ForeName>Farimah</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vahidi Mehrjardi</LastName>
            <ForeName>Mohammad Yahya</ForeName>
            <Initials>MY</Initials>
            <AffiliationInfo>
              <Affiliation>Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Center for Food Hygiene and Safety, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Eur J Obstet Gynecol Reprod Biol X</MedlineTA>
        <NlmUniqueID>101750520</NlmUniqueID>
        <ISSNLinking>2590-1613</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Endometriosis</Keyword>
        <Keyword MajorTopicYN="N">MAPK</Keyword>
        <Keyword MajorTopicYN="N">NF1</Keyword>
        <Keyword MajorTopicYN="N">PI3K / Akt</Keyword>
        <Keyword MajorTopicYN="N">RASA1</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>2</Hour>
          <Minute>30</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35586752</ArticleId>
        <ArticleId IdType="pmc">PMC9109175</ArticleId>
        <ArticleId IdType="doi">10.1016/j.eurox.2022.100152</ArticleId>
        <ArticleId IdType="pii">S2590-1613(22)00012-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Osiński M., Wirstlein P., Wender-Ożegowska E., Mikołajczyk M., Jagodziński P.P., Szczepańska M. HSD3B2, HSD17B1, HSD17B2, ESR1, ESR2 and AR expression in infertile women with endometriosis. Ginekol. Polska. 2018;89(3):125–134.</Citation>
        </Reference>
        <Reference>
          <Citation>Haikalis M.E., Wessels J.M., Leyland N.A., Agarwal S.K., Foster W.G. MicroRNA expression pattern differs depending on endometriosis lesion type. Biol. Reprod. 2018;98(5):623–633.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29385395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petracco R., Dias A.C.D.O., Taylor H.S., Petracco Á., Badalotti M., Michelon J.D.R., et al.  Evaluation of miR‑135a/b expression in endometriosis lesions. Biomed. Rep. 2019;11(4):181–187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6759580</ArticleId>
            <ArticleId IdType="pubmed">31565224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyashita M., Koga K., Takeuchi A., Makabe T., Taguchi A., Urata Y., et al.  Expression of nerve injury-induced protein1 (Ninj1) in endometriosis. Reprod. Sci. 2018;26(8):1105–1110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30326781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bjorkman S., Taylor H.S. MicroRNAs in endometriosis: biological function and emerging biomarker candidates. Biol. Reprod. 2019;101(6):1167–1178.</Citation>
        </Reference>
        <Reference>
          <Citation>Hu Z., Mamillapalli R., Taylor H.S. Increased circulating miR-370-3p regulates steroidogenic factor 1 in endometriosis. Am. J. Physiol. Endocrinol. Metabol. 2019;316(3):E373–E382.</Citation>
        </Reference>
        <Reference>
          <Citation>Wuyung P.E., Rahadiati F.B., Hartono Tjahjadi S.S., Kusmardi K., Kodariah R., Wiweko B. Histopathology and ARID1A expression in endometriosis-associated ovarian carcinoma (EAOC) carcinogenesis model with endometrial autoimplantation and DMBA induction. Asian Pac. J. Cancer Prevent. APJCP. 2021;22(2):553.</Citation>
        </Reference>
        <Reference>
          <Citation>Malvezzi H., Marengo E.B., Podgaec S., de Azevedo Piccinato C. Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology. J. Transl. Med. 2020;18(1):1–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6941297</ArticleId>
            <ArticleId IdType="pubmed">31900168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouaziz J., Mashiach R., Cohen S., Kedem A., Baron A., Zajicek M., et al.  How artificial intelligence can improve our understanding of the genes associated with endometriosis: natural language processing of the PubMed Database. BioMed Res. Int. 2018;2018</Citation>
        </Reference>
        <Reference>
          <Citation>Cheng A.M., Saxton T.M., Sakai R., Kulkarni S., Mbamalu G., Vogel W., et al.  Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell. 1998;95(6):793–803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9865697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim E.K., Choi E.-J. Compromised MAPK signaling in human diseases: an update. Arch. Toxicol. 2015;89(6):867–882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25690731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watanabe T., Shinohara N., Moriya K., Sazawa A., Kobayashi Y., Ogiso Y., et al.  Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines. IUBMB Life. 2000;49(4):317–320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10995035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nichols R.J., Haderk F., Stahlhut C., Schulze C.J., Hemmati G., Wildes D., et al.  Efficacy of SHP2 phosphatase inhibition in cancers with nucleotide-cycling oncogenic RAS, RAS-GTP dependent oncogenic BRAF and NF1 loss. bioRxiv. 2017</Citation>
        </Reference>
        <Reference>
          <Citation>Erdogan S., Turkekul K., Dibirdik I., Doganlar O., Doganlar Z.B., Bilir A., et al.  Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway. Biomed. Pharmacother. 2018;107:793–805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30142541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellazzo A., Collavin L. Cutting the brakes on ras—cytoplasmic GAPs as targets of inactivation in cancer. Cancers. 2020;12(10):3066.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang Y., Li Y., Wang Q., Su B., Xu H., Sun Y., et al.  Role of RASA1 in cancer: a review and update. Oncol. Rep. 2020</Citation>
        </Reference>
        <Reference>
          <Citation>Brosseau J.-P., Liao C.-P., Wang Y., Ramani V., Vandergriff T., Lee M., et al.  NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. Nat. Commun. 2018;9(1):1–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5760687</ArticleId>
            <ArticleId IdType="pubmed">29317637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freytag D., Mettler L., Maass N., Günther V., Alkatout I. Uterine anomalies and endometriosis. Minerva Med. 2019;111(1):33–49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31755672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murakami K., Kotani Y., Nakai H., Matsumura N. Endometriosis-associated ovarian cancer: the origin and targeted therapy. Cancers. 2020;12(6):1676.</Citation>
        </Reference>
        <Reference>
          <Citation>McCluggage W.G. Endometriosis‐related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions. Histopathology. 2020;76(1):76–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31846535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melin A., Sparen P., Persson I., Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Human Reprod. 2006;21(5):1237–1242.</Citation>
        </Reference>
        <Reference>
          <Citation>Guo Y.J., Pan W.W., Liu S.B., Shen Z.F., Xu Y., Hu L.L. ERK/MAPK signalling pathway and tumorigenesis. Exp. Ther. Med. 2020;19(3):1997–2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7027163</ArticleId>
            <ArticleId IdType="pubmed">32104259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rezatabar S., Karimian A., Rameshknia V., Parsian H., Majidinia M., Kopi T.A., et al.  RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression. J. Cell. Physiol. 2019;234(9):14951–14965.</Citation>
        </Reference>
        <Reference>
          <Citation>Barra F., Desideri L.F., Ferrero S. Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis. Br. J. Pharmacol. 2018;175(17):3626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6086976</ArticleId>
            <ArticleId IdType="pubmed">29984446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butler D.E., Marlein C., Walker H.F., Frame F.M., Mann V.M., Simms M.S., et al.  Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer. Oncotarget. 2017;8(34):56698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5593594</ArticleId>
            <ArticleId IdType="pubmed">28915623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li L., Fan Y., Huang X., Luo J., Zhong L., Shu X-s, et al.  Tumor suppression of Ras GTPase-activating protein RASA5 through antagonizing Ras signaling perturbation in carcinomas. Iscience. 2019;21:1–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6820368</ArticleId>
            <ArticleId IdType="pubmed">31654850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao W., Zheng S., Zou Y., Yang A., Xie X., Tang H., et al.  CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1. Aging. 2019;11(24):12043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6949091</ArticleId>
            <ArticleId IdType="pubmed">31857500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao Y., Chu C., Li X., Gu S., Zou Q., Jin Y. RNA-binding protein QKI suppresses breast cancer via RASA1/MAPK signaling pathway. Ann. Transl. Med. 2021;9(2)</Citation>
        </Reference>
        <Reference>
          <Citation>Hu J., Wang L., Chen J., Gao H., Zhao W., Huang Y., et al.  The circular RNA circ-ITCH suppresses ovarian carcinoma progression through targeting miR-145/RASA1 signaling. Biochem. Biophys. Res. Commun. 2018;505(1):222–228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30243714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du C., Weng X., Hu W., Lv Z., Xiao H., Ding C., et al.  Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 2015;34(1):1–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4311464</ArticleId>
            <ArticleId IdType="pubmed">25592960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samimi M., Pourhanifeh M.H., Mehdizadehkashi A., Eftekhar T., Asemi Z. The role of inflammation, oxidative stress, angiogenesis, and apoptosis in the pathophysiology of endometriosis: basic science and new insights based on gene expression. J. Cell. Physiol. 2019;234(11):19384–19392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31004368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osum S.H., Coutts A.W., Duerre D.J., Tschida B.R., Kirstein M.N., Fisher J., et al.  Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo. Neuro Oncol. Adv. 2021;3(1):vdab020.</Citation>
        </Reference>
        <Reference>
          <Citation>Kiuru M., Busam K.J. The NF1 gene in tumor syndromes and melanoma. Lab. Invest. 2017;97(2):146–157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5413358</ArticleId>
            <ArticleId IdType="pubmed">28067895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su J., Ruan S., Dai S., Mi J., Chen W., Jiang S. NF1 regulates apoptosis in ovarian cancer cells by targeting MCL1 via miR-142–5p. Pharmacogenomics. 2019;20(03):155–165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30543142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo S.W. Cancer driver mutations in endometriosis: variations on the major theme of fibrogenesis. Reprod. Med. Biol. 2018;17(4):369–397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6194252</ArticleId>
            <ArticleId IdType="pubmed">30377392</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
